Public Comments
Midwest CEPAC

PDF cover

Ovarian Cancer: Public Comments

Public comments received on ICER’s Draft Evidence Report on PARP inhibitors for ovarian cancer.

View

View All Materials on this Topic or Go Back to View More Materials